Display options
Cite
Venugopal A. Disseminated intravascular coagulation. Indian J Anaesth. 2014;58(5):603-8doi: 10.4103/0019-5049.144666.
Venugopal, A. (2014). Disseminated intravascular coagulation. Indian journal of anaesthesia, 58(5), 603-8. https://doi.org/10.4103/0019-5049.144666
Venugopal, A. "Disseminated intravascular coagulation." Indian journal of anaesthesia vol. 58,5 (2014): 603-8. doi: https://doi.org/10.4103/0019-5049.144666
Venugopal A. Disseminated intravascular coagulation. Indian J Anaesth. 2014 Sep;58(5):603-8. doi: 10.4103/0019-5049.144666. PMID: 25535423; PMCID: PMC4260307.
Copy Download .nbib Format: NLM
Share it on

Indian J Anaesth. 2014 Sep;58(5):603-8. doi: 10.4103/0019-5049.144666.

Disseminated intravascular coagulation.

Indian journal of anaesthesia

A Venugopal

Affiliations

  1. Department of Anaesthesiology, Regional Cancer Centre, Medical College Campus, Thiruvanathapuram, Kerala, India.

PMID: 25535423 PMCID: PMC4260307 DOI: 10.4103/0019-5049.144666

Abstract

Disseminated intravascular coagulation (DIC) is a reflection of an underlying systemic disorder which affects the coagulation system, simultaneously resulting in pro-coagulant activation, fibrinolytic activation, and consumption coagulopathy and finally may result in organ dysfunction and death. Though septicaemia is the most common cause of DIC, several other conditions can also lead to it. A diagnosis of DIC should be made only in the presence of a causative factor supported by repeated laboratory tests for coagulation profile and clotting factors. An effective scoring system helps to detect an overt DIC and a high score closely correlates with mortality. Treatment of DIC is aimed at combating the underlying disorder followed by supportive management. Low molecular weight heparin is advocated in special situations whereas anti-thrombin III and activated protein C are of doubtful value. Early diagnosis and prompt treatment backed by laboratory support can reduce the morbidity and mortality associated with it. The methodology of search for this review article involved hand search from text books and internet search using Medline (via PubMed) using key words DIC, thrombosis, fibrin degradation products, anti-thrombin and tissue factor for the last 25 years and also recent evidence-based reviews.

Keywords: Activated protein C; anti-thrombin; coagulation factors; disseminated intravascular coagulation; fibrin degradation products; thrombosis; tissue factor

References

  1. Thromb Res. 2001 Jun 15;102(6):V215-24 - PubMed
  2. Crit Care Med. 2006 Feb;34(2):314-20; quiz 328 - PubMed
  3. Eur J Haematol. 2001 Sep;67(3):170-5 - PubMed
  4. Haemostasis. 2001;31 Suppl 1:47-8 - PubMed
  5. Crit Care Med. 2001 Jul;29(7 Suppl):S90-4 - PubMed
  6. N Engl J Med. 1999 Jan 21;340(3):207-14 - PubMed
  7. Int J Lab Hematol. 2014 Jun;36(3):228-36 - PubMed
  8. Intensive Care Med. 2005 Sep;31(9):1209-14 - PubMed
  9. Crit Care Med. 2002 Apr;30(4):753-6 - PubMed
  10. Thromb Haemost. 2001 Nov;86(5):1327-30 - PubMed
  11. N Engl J Med. 2001 Aug 9;345(6):408-16 - PubMed
  12. Semin Thromb Hemost. 2001 Dec;27(6):585-92 - PubMed
  13. Thromb Haemost. 2001 Jul;86(1):51-6 - PubMed
  14. Minerva Anestesiol. 2013 Mar;79(3):294-8 - PubMed
  15. N Engl J Med. 1999 Aug 19;341(8):586-92 - PubMed
  16. Am J Hematol. 1997 Aug;55(4):169-74 - PubMed
  17. Thromb Haemost. 1999 Aug;82(2):695-705 - PubMed
  18. Thromb Haemost. 1998 Jul;80(1):65-9 - PubMed
  19. Blood. 1996 Aug 1;88(3):881-6 - PubMed
  20. Br J Haematol. 1989 Jan;71(1):65-70 - PubMed
  21. BMJ. 2003 Oct 25;327(7421):974-7 - PubMed
  22. Br J Haematol. 2009 Apr;145(1):24-33 - PubMed
  23. Clin Nephrol. 1992 Aug;38(2):90-6 - PubMed
  24. Am J Hematol. 2006 Jun;81(6):414-9 - PubMed
  25. J Clin Invest. 1994 Jan;93(1):114-20 - PubMed
  26. Blood. 2000 Feb 15;95(4):1124-9 - PubMed
  27. Crit Care Med. 2004 Dec;32(12):2416-21 - PubMed
  28. Crit Care. 2006;10(4):222 - PubMed
  29. Clin Appl Thromb Hemost. 2006 Apr;12(2):185-92 - PubMed

Publication Types